GO
| HSI1 | 25,872.32 | 0.00 | -- |
| HSCEI1 | 8,671.61 | 0.00 | -- |
| Back Zoom + Zoom - Block Traded | |
|
2026-04-14 11:08:29 BofA Securities issued a research report expecting ALI HEALTH (00241.HK)'s FY2026 revenue to be in line with expectation. Taking into account the Company's investments in AI and innovative drug sales businesses since 2H, the broker lowered its FY2026 adjusted net profit forecast to a YoY increase of 20% (previously projected at 35%). Therefore, BofA Securities dropped its target price for ALI HEALTH from $6.56 to $6, with rating reiterated at Buy. ~ AASTOCKS Financial News Website: www.aastocks.com | |